Centessa Pharmaceuticals annuncia la partecipazione alla XIX edizione della Global Healthcare Conference annuale virtuale di Morgan Stanley
September 02, 2021 14:20 ET
|
Centessa Pharmaceuticals plc
CAMBRIDGE, Mass. e LONDRA, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) ha annunciato oggi la partecipazione di Saurabh Saha, M.D., Ph.D e Chief Executive Officer,...
Centessa Pharmaceuticals fera une présentation lors de la 19e conférence mondiale annuelle virtuelle Morgan Stanley sur les soins de santé
September 02, 2021 14:20 ET
|
Centessa Pharmaceuticals plc
CAMBRIDGE, Massachusetts & LONDRES, 02 sept. 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq : CNTA) a annoncé aujourd'hui que Saurabh Saha, M.D., Ph.D., président-directeur...
Centessa Pharmaceuticals aanwezig op virtuele 19e jaarlijkse Global Healthcare Conference van Morgan Stanley
September 02, 2021 14:20 ET
|
Centessa Pharmaceuticals plc
CAMBRIDGE, Massachusetts en LONDEN, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) kondigde vandaag aan dat Saurabh Saha, M.D., Ph.D., Chief Executive Officer, zal...
Centessa Pharmaceuticals to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference
September 01, 2021 16:15 ET
|
Centessa Pharmaceuticals plc
CAMBRIDGE, Mass. & LONDON, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that Saurabh Saha, M.D., Ph.D., Chief Executive Officer, will...
Centessa Pharmaceuticals Announces Second Quarter 2021 Financial Results and Business Updates
August 16, 2021 07:00 ET
|
Centessa Pharmaceuticals plc
~ Successful completion of an initial public offering of American Depositary Shares raising gross proceeds of $379.5 million to help advance portfolio of 16 clinical and preclinical programs ~ ~...
Centessa Pharmaceuticals to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
June 07, 2021 16:15 ET
|
Centessa Pharmaceuticals plc
CAMBRIDGE, Mass. and LONDON, June 07, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced today that Saurabh Saha, M.D., Ph.D., Chief Executive Officer, will participate...
Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
June 04, 2021 16:15 ET
|
Centessa Pharmaceuticals plc
CAMBRIDGE, Mass. and LONDON, June 04, 2021 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (“Centessa”), a clinical-stage company employing its innovative asset-centric business model to...